480 related articles for article (PubMed ID: 28148395)
21. Protease-activated receptor 2 (PAR2) mediates vascular smooth muscle cell migration induced by tissue factor/factor VIIa complex.
Marutsuka K; Hatakeyama K; Sato Y; Yamashita A; Sumiyoshi A; Asada Y
Thromb Res; 2002 Sep; 107(5):271-6. PubMed ID: 12479889
[TBL] [Abstract][Full Text] [Related]
22. Inhibition of tissue factor/protease-activated receptor-2 signaling limits proliferation, migration and invasion of malignant glioma cells.
Gessler F; Voss V; Dützmann S; Seifert V; Gerlach R; Kögel D
Neuroscience; 2010 Feb; 165(4):1312-22. PubMed ID: 19958818
[TBL] [Abstract][Full Text] [Related]
23. Involvement of PKCα activation in TF/VIIa/PAR2-induced proliferation, migration, and survival of colon cancer cell SW620.
Wu B; Zhou H; Hu L; Mu Y; Wu Y
Tumour Biol; 2013 Apr; 34(2):837-46. PubMed ID: 23233043
[TBL] [Abstract][Full Text] [Related]
24. Tyrosine kinase A receptor (trkA): a potential marker in epithelial ovarian cancer.
Tapia V; Gabler F; Muñoz M; Yazigi R; Paredes A; Selman A; Vega M; Romero C
Gynecol Oncol; 2011 Apr; 121(1):13-23. PubMed ID: 21236475
[TBL] [Abstract][Full Text] [Related]
25. Apixaban Suppresses the Release of TF-Positive Microvesicles and Restrains Cancer Cell Proliferation through Directly Inhibiting TF-fVIIa Activity.
Featherby S; Madkhali Y; Maraveyas A; Ettelaie C
Thromb Haemost; 2019 Sep; 119(9):1419-1432. PubMed ID: 31266079
[TBL] [Abstract][Full Text] [Related]
26. Involvement of ERK1/2/NF-κB signal transduction pathway in TF/FVIIa/PAR2-induced proliferation and migration of colon cancer cell SW620.
Guo D; Zhou H; Wu Y; Zhou F; Xu G; Wen H; Zhang X
Tumour Biol; 2011 Oct; 32(5):921-30. PubMed ID: 21625939
[TBL] [Abstract][Full Text] [Related]
27. Microarray studies of factor VIIa-activated cancer cells.
Petersen LC
Thromb Res; 2008; 122 Suppl 1():S11-3. PubMed ID: 18691491
[TBL] [Abstract][Full Text] [Related]
28. Regulation of tissue factor-induced signaling by endogenous and recombinant tissue factor pathway inhibitor 1.
Ahamed J; Belting M; Ruf W
Blood; 2005 Mar; 105(6):2384-91. PubMed ID: 15550483
[TBL] [Abstract][Full Text] [Related]
29. Modulation of tissue factor-factor VIIa signaling by lipid rafts and caveolae.
Awasthi V; Mandal SK; Papanna V; Rao LV; Pendurthi UR
Arterioscler Thromb Vasc Biol; 2007 Jun; 27(6):1447-55. PubMed ID: 17413039
[TBL] [Abstract][Full Text] [Related]
30. Tissue factor trafficking in fibroblasts: involvement of protease-activated receptor-mediated cell signaling.
Mandal SK; Pendurthi UR; Rao LV
Blood; 2007 Jul; 110(1):161-70. PubMed ID: 17384202
[TBL] [Abstract][Full Text] [Related]
31. The epidermal growth factor receptor (EGFR) and proline rich tyrosine kinase 2 (PYK2) are involved in tissue factor dependent factor VIIa signalling in HaCaT cells.
Wiiger MT; Prydz H
Thromb Haemost; 2004 Jul; 92(1):13-22. PubMed ID: 15213840
[TBL] [Abstract][Full Text] [Related]
32. MicroRNA-145 targets TRIM2 and exerts tumor-suppressing functions in epithelial ovarian cancer.
Chen X; Dong C; Law PT; Chan MT; Su Z; Wang S; Wu WK; Xu H
Gynecol Oncol; 2015 Dec; 139(3):513-9. PubMed ID: 26472353
[TBL] [Abstract][Full Text] [Related]
33. Cyclin I mRNA expression correlates with kinase insert domain receptor expression in human epithelial ovarian cancer.
Cybulski M; Jeleniewicz W; Nowakowski A; Stenzel-Bembenek A; Tarkowski R; Kotarski J; Stepulak A
Anticancer Res; 2015 Feb; 35(2):1115-9. PubMed ID: 25667501
[TBL] [Abstract][Full Text] [Related]
34. MMP-1-PAR1 axis mediates LPA-induced epithelial ovarian cancer (EOC) invasion.
Wang FQ; Fisher J; Fishman DA
Gynecol Oncol; 2011 Feb; 120(2):247-55. PubMed ID: 21093894
[TBL] [Abstract][Full Text] [Related]
35. Cellular consequences upon factor VIIa binding to tissue factor.
Siegbahn A
Haemostasis; 2000; 30 Suppl 2():41-7. PubMed ID: 11251340
[TBL] [Abstract][Full Text] [Related]
36. Sam68 is Overexpressed in Epithelial Ovarian Cancer and Promotes Tumor Cell Proliferation.
Dong L; Che H; Li M; Li X
Med Sci Monit; 2016 Sep; 22():3248-56. PubMed ID: 27623016
[TBL] [Abstract][Full Text] [Related]
37. TF/FVIIa transactivate PDGFRbeta to regulate PDGF-BB-induced chemotaxis in different cell types: involvement of Src and PLC.
Siegbahn A; Johnell M; Nordin A; Aberg M; Velling T
Arterioscler Thromb Vasc Biol; 2008 Jan; 28(1):135-41. PubMed ID: 17991872
[TBL] [Abstract][Full Text] [Related]
38. Exclusion of known protease-activated receptors in factor VIIa-induced signal transduction.
Petersen LC; Thastrup O; Hagel G; Sørensen BB; Freskgård PO; Rao LV; Ezban M
Thromb Haemost; 2000 Apr; 83(4):571-6. PubMed ID: 10780319
[TBL] [Abstract][Full Text] [Related]
39. Cortactin activation by FVIIa/tissue factor and PAR2 promotes endothelial cell migration.
Zhu T; Mancini JA; Sapieha P; Yang C; Joyal JS; Honoré JC; Leduc M; Zaniolo K; Hardy P; Shao Z; Fan L; Hou X; Rivard GE; Chemtob S
Am J Physiol Regul Integr Comp Physiol; 2011 Mar; 300(3):R577-85. PubMed ID: 21160057
[TBL] [Abstract][Full Text] [Related]
40. Pyridoxine 5'-phosphate oxidase is a novel therapeutic target and regulated by the TGF-β signalling pathway in epithelial ovarian cancer.
Zhang L; Zhou D; Guan W; Ren W; Sun W; Shi J; Lin Q; Zhang J; Qiao T; Ye Y; Wu Y; Zhang Y; Zuo X; Connor KL; Xu G
Cell Death Dis; 2017 Dec; 8(12):3214. PubMed ID: 29238081
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]